Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 5 clients • 6 examiners • 6 art units • 0 of 6 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Hunt IP Law specializes in the Biotechnology & Pharmaceuticals technology area. The firm has managed 233 career applications, demonstrating a focused portfolio in this specialized sector. Its resolved allowance rate pct of 67.42 indicates the frequency of successful outcomes for its clients across its resolved cases. This rate reflects the firm's engagement with the rigorous examination standards typical of biotechnology patents.
The firm currently has 6 pending office actions, representing its active engagement with the patent office. On average, the firm reaches an allowance after 2.7 avg office actions per allowance. This metric reflects the typical intensity of the prosecution cycle required to move an application to issuance. The 67.42 resolved allowance rate pct and 2.7 avg office actions per allowance characterize the firm's performance in navigating the specific challenges of the Biotechnology & Pharmaceuticals field for its 233 career applications. These metrics offer insight into the firm's historical success and efficiency.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (33%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
| No statute on record | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BORI, IBRAHIM D | 1 | 43.8% | +38.9% |
| FRONDA, CHRISTIAN L | 1 | 82.4% | +14.2% |
| BYRNES, DAVID R | 1 | 78.1% | +22.2% |
| KRUSE, DAVID H | 1 | 81.3% | +9.6% |
| LEE, SIN J | 1 | 68.8% | +25.1% |
| SASAN, ARADHANA | 1 | 64.5% | +26.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18734722 | HEMP SEED PRODUCTS AND METHODS AND SYSTEMS FOR PRODUCING SAME | FRONDA, CHRISTIAN L | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18000918 | HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME | SASAN, ARADHANA | 126d overdue |
| 18409352 | CANNABIS PLANT NAMED 'CK2015' | KRUSE, DAVID H | 66d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18000918 | HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME | SASAN, ARADHANA | 126d overdue |
| 18750843 | HIGH POTENCY EMULSIONS | BORI, IBRAHIM D | 9d overdue |
| 18734722 | HEMP SEED PRODUCTS AND METHODS AND SYSTEMS FOR PRODUCING SAME | FRONDA, CHRISTIAN L | — |
| 18409264 | CANNABIS PLANT NAMED 'BF2014' | BYRNES, DAVID R | — |
| 18490538 | TREATMENT OF GASTROINTESTINAL DISORDERS | LEE, SIN J | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Cbiotix, LLC | 2 |
| Vertosa Inc. | 1 |
| VICTORY FOODS, PBC | 1 |
| Greenspace Labs, Inc. | 1 |
| CReDO Science, LLC | 1 |
| Art Unit | Apps |
|---|---|
| 1629 | 1 |
| 1652 | 1 |
| 1662 | 1 |
| 1663 | 1 |
| 1613 | 1 |
| 1615 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18750843 | HIGH POTENCY EMULSIONS | Vertosa Inc. | BORI, IBRAHIM D | 1629 | — | Final Rejection | 9d overdue | Pending | Jun 21, 2024 |
| 18734722 | HEMP SEED PRODUCTS AND METHODS AND SYSTEMS FOR PRODUCING SAME | VICTORY FOODS, PBC | FRONDA, CHRISTIAN L | 1652 | §103DP | Final Rejection | — | Pending | Jun 05, 2024 |
| 18409264 | CANNABIS PLANT NAMED 'BF2014' | Cbiotix, LLC | BYRNES, DAVID R | 1662 | §103 | Final Rejection | — | Pending | Jan 10, 2024 |
| 18409352 | CANNABIS PLANT NAMED 'CK2015' | Cbiotix, LLC | KRUSE, DAVID H | 1663 | §103§112 | Final Rejection | 66d overdue | Pending | Jan 10, 2024 |
| 18490538 | TREATMENT OF GASTROINTESTINAL DISORDERS | Greenspace Labs, Inc. | LEE, SIN J | 1613 | §103 | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18000918 | HEMP SPROUT PRODUCTS AND METHODS FOR PRODUCING SAME | Credo Science, LLC | SASAN, ARADHANA | 1615 | §103§112 | Final Rejection | 126d overdue | Pending | Dec 06, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial